In addition, modifications altering Drp-1 activity and followed mitochondrial fragmentation have been linked to human neuro-degenerative pathologies, including Alzheimer’s, Parkinson’s and Huntington’s disease [10,16]. This evidence concerns the gene DNM1L and juvenile Huntington disease.